yup, good call. Good and meh ann
- no guarantee that AT1 will be able to sell 20m kits (prof + self-test) in AU market, but so far it appears that sales are doing well from company updates and news articles. Nevertheless having confirmed kit supply is good + consumer self-test approval potential is gr8 too...considering AU is our backyard and all the approvals to date, company really has to show it can sell mucho quantities here. Actually moving 20m kits in a reluctant market like AU would be a gr8 boost for brand recognition and cashflow
- meh news because another OEM agreement is gone/didn't commercialise into a regular thing for AT1's platform. Despite its uniqueness + safety potential, AT1 is still square 1 for expanding its commercial biz. Onto waiting some more for these US + China opp mentioned....
- Forums
- ASX - By Stock
- AT1
- Ann: Atomo and Access Bio renegotiate supply agreements
Ann: Atomo and Access Bio renegotiate supply agreements, page-11
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
0.001(4.55%) |
Mkt cap ! $14.70M |
Open | High | Low | Value | Volume |
2.0¢ | 2.3¢ | 2.0¢ | $1.21K | 55.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 314348 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 152314 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 314348 | 0.020 |
5 | 604260 | 0.019 |
9 | 1162558 | 0.018 |
3 | 410000 | 0.017 |
1 | 62561 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 99683 | 1 |
0.024 | 631111 | 3 |
0.025 | 459000 | 2 |
0.026 | 1590045 | 4 |
0.027 | 683000 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
AT1 (ASX) Chart |